Cartesian Therapeutics Inc —— 财务报表 (NASDAQ:RNAC) | MetaTrader

展开完整图表

新闻

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BTIG重申Cartesian Therapeutics股票买入评级,目标价44美元

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

瑞穗重申Cartesian Therapeutics评级,看好试验进展

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

H.C. Wainwright下调Cartesian Therapeutics股票目标价从40美元至30美元

H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40

Cartesian: Maintaining Buy Rating For Expansion Of Descartes-08 For Myositis (NASDAQ:RNAC)